Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bacterial Infections and Mycoses

Free Subscription Articles published in Nat Med Retrieve available abstracts of 23 articles: HTML format

Single Articles

April 2024
1. 
   Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness.
   Nat Med. 2024 Apr 3. doi: 10.1038/s41591-024-02907.
   PubMed    
   
   
   March 2024
2. NUERMBERGER EL, Chaisson RE
   Restocking the tuberculosis drug arsenal.
   Nat Med. 2024 Mar 8. doi: 10.1038/s41591-024-02840.
   PubMed    
   
   
   
3. XU H, Zou K, Dent J, Wiens KE, et al
   Enhanced cholera surveillance to improve vaccination campaign efficiency.
   Nat Med. 2024 Mar 5. doi: 10.1038/s41591-024-02852.
   PubMed     Abstract available
   
   
   
4. HEGDE ST, Khan AI, Perez-Saez J, Khan II, et al
   Clinical surveillance systems obscure the true cholera infection burden in an endemic region.
   Nat Med. 2024;30:888-895.
   PubMed     Abstract available
   
   
   
5. KHAN S, Guo X, Awan UA
   Pakistan is failing in maternal and neonatal tetanus elimination.
   Nat Med. 2024;30:615.
   PubMed    
   
   
   February 2024
6. O'LEARY K
   Digital intervention improves tuberculosis treatment outcomes.
   Nat Med. 2024 Feb 19. doi: 10.1038/d41591-024-00009.
   PubMed    
   
   
   
7. DIACON AH, Barry CE 3rd, Carlton A, Chen RY, et al
   A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
   Nat Med. 2024 Feb 16. doi: 10.1038/s41591-024-02829.
   PubMed     Abstract available
   
   
   January 2024
8. NAKAGAAYI D, Pulle J, Otim I, Akiya OC, et al
   A decentralized delivery program for rheumatic heart disease treatment and prevention in Uganda.
   Nat Med. 2024;30:12-13.
   PubMed    
   
   
   December 2023
9. ACKERMAN L, Acloque G, Bacchelli S, Schwartz H, et al
   IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
   Nat Med. 2023;29:3127-3136.
   PubMed     Abstract available
   
   
   October 2023
10. GRILLO S, Pujol M, Miro JM, Lopez-Contreras J, et al
    Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
    Nat Med. 2023 Oct 2. doi: 10.1038/s41591-023-02569.
    PubMed     Abstract available
    
    
    
11. 
    Genomic epidemiology of Clostridioides difficile in individuals admitted to an intensive care unit.
    Nat Med. 2023;29:2418-2419.
    PubMed    
    
    
    
12. MILES-JAY A, Snitkin ES, Lin MY, Shimasaki T, et al
    Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit.
    Nat Med. 2023;29:2526-2534.
    PubMed     Abstract available
    
    
    
13. TANUI CK, Tessema SK, Tegegne MA, Tebeje YK, et al
    Unlocking the power of molecular and genomics tools to enhance cholera surveillance in Africa.
    Nat Med. 2023;29:2387-2388.
    PubMed    
    
    
    August 2023
14. JOHNSON B
    GSK's gonorrhea vaccine receives fast-track designation to expedite clinical trials.
    Nat Med. 2023 Aug 7. doi: 10.1038/d41591-023-00069.
    PubMed    
    
    
    March 2023
15. ESMAIL A, Randall P, Oelofse S, Tomasicchio M, et al
    Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial.
    Nat Med. 2023 Mar 9. doi: 10.1038/s41591-023-02247.
    PubMed     Abstract available
    
    
    January 2023
16. MCKENNA L, Frick M, Angami K, Dubula V, et al
    The 1/4/6x24 campaign to cure tuberculosis quickly.
    Nat Med. 2023 Jan 10. doi: 10.1038/s41591-022-02136.
    PubMed    
    
    
    
17. MUSVOSVI M, Huang H, Wang C, Xia Q, et al
    T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
    Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02110.
    PubMed     Abstract available
    
    
    
18. OGONGO P, Ernst JD
    Finding antigens for TB vaccines: the good, the bad and the useless.
    Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02123.
    PubMed    
    
    
    November 2022
19. CARVALHO T
    A new class of antibiotics delivers promising trial results against tuberculosis.
    Nat Med. 2022 Nov 30. doi: 10.1038/d41591-022-00114.
    PubMed    
    
    
    September 2022
20. IANIRO G, Puncochar M, Karcher N, Porcari S, et al
    Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Nat Med. 2022;28:1913-1923.
    PubMed     Abstract available
    
    
    
21. SCHMIDT TSB, Li SS, Maistrenko OM, Akanni W, et al
    Drivers and determinants of strain dynamics following fecal microbiota transplantation.
    Nat Med. 2022;28:1902-1912.
    PubMed     Abstract available
    
    
    
22. ISLAM MT, Ross AG, Sleigh AC, Chowdhury F, et al
    A blueprint for eliminating cholera by 2030.
    Nat Med. 2022;28:1747-1749.
    PubMed    
    
    
    January 2022
23. SINHA S, Rosin NL, Arora R, Labit E, et al
    Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
    Nat Med. 2022;28:201-211.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.